SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Hover over the logos to learn more about the companies who made this project possible.
SynapCon specialises in the development of innovative software solutions for...
SOM Biotech is an Artificial Intelligence AI drug discovery and...
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
SOM0208 is a small molecule for the treatment of Niemann–Pick C disease.
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...